The Effect of Aerobic Exercise on Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Burn Patients: A Randomized Controlled Study
Launched by HASAN KALYONCU UNIVERSITY · Aug 22, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how aerobic exercise can affect certain blood cell ratios in patients who have suffered burns. Specifically, the study focuses on the neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and lymphocyte-monocyte ratio, which are important indicators of health and recovery. Participants will be divided into two groups to compare the effects of different exercise routines. The goal is to see if regular aerobic exercise can help improve these blood measurements in burn patients.
To be eligible for the trial, participants must be at least 18 years old, conscious, and able to eat normally. However, individuals with inhalation burns, other serious injuries, or existing health conditions like diabetes or heart problems will not be included. If you join the study, you can expect to participate in an exercise program and contribute to valuable research that may help improve recovery for burn patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Inclusion Criteria:
- • Conscious patients Enterally fed \>18 years old
- Exclusion Criteria:
- • With inhalation burn In addition to existing burn trauma, those with other trauma (fracture, loss of limb, etc.) Organ dysfunctions or multiple organ failure History of chronic diseases such as diabetes, cholesterol and blood pressure
- • -
About Hasan Kalyoncu University
Hasan Kalyoncu University is a distinguished academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. By fostering collaboration among researchers, healthcare professionals, and industry partners, Hasan Kalyoncu University strives to contribute to the development of effective therapies and interventions, ultimately aiming to address pressing health challenges and promote public well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gaziantep, , Turkey
Patients applied
Trial Officials
MURAT A ÇINAR, DR
Principal Investigator
Hasan Kalyoncu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported